Search Results - "Hauss, David"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Oral lipid-based formulations by Hauss, David J.

    Published in Advanced drug delivery reviews (30-07-2007)
    “…Poor drug solubility remains a significant and frequently encountered problem for pharmaceutical scientists. The ability of lipid-based formulations to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor by Hauss, D J, Fogal, S E, Ficorilli, J V, Price, C A, Roy, T, Jayaraj, A A, Keirns, J J

    Published in Journal of pharmaceutical sciences (01-02-1998)
    “…Ontazolast is a potent inhibitor (IC50 = 1 nm) of calcium ionophore A23187-stimulated leukotriene B4 (LTB4) biosynthesis in human peripheral blood leukocytes…”
    Get more information
    Journal Article
  4. 4

    The influence of concentration of two salicylate derivatives on rectal insulin absorption enhancement by Hauss, D J, Ando, H Y

    Published in Journal of pharmacy and pharmacology (01-09-1988)
    “…3,5-Diiodosalicylate sodium (DIS), a highly lipophilic salicylate, was evaluated against 5-methoxysalicylate sodium (MS) as a potential adjuvant absorption…”
    Get more information
    Journal Article
  5. 5

    Chronic Collection of Mesenteric Lymph From Conscious, Tethered Rats by Hauss, David, Fogal, Steven, Ficorilli, James

    “…Previously reported methods for collecting lymph from the rat require total restraint of the animal and fluid replacement, by intravenous or intraduodenal…”
    Get full text
    Journal Article
  6. 6

    Rat and rabbit plasma distribution of free and chylomicron-associated BIRT 377, a novel small molecule antagonist of LFA-1-mediated cell adhesion by WASAN, Kishor M, RAMASWAMY, Manisha, HOLTORF, Lorilynne, JAYARAJ, Andrew A, HAUSS, David J

    Published in Pharmaceutical research (01-04-2001)
    “…The objectives of this study are to determine the plasma distribution of free and chylomicron-associated BIRT 377 within rats and rabbits. For the rat studies…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Determination of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)-dodecanamide, a lipid regulator, in rat plasma and mesenteric lymph by reversed-phase high-performance liquid chromatography by Hauss, D J, Martin, P J, Mehta, S C, Radebaugh, G W

    Published in Journal of chromatography (02-04-1993)
    “…2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (I, CI-976) has been determined in rat mesenteric lymph and plasma using a rapid and sensitive…”
    Get more information
    Journal Article
  9. 9

    The relationship of salicylate lipophilicity to rectal insulin absorption enhancement and relative lymphatic uptake by Hauss, D J, Ando, H Y, Grasela, D M, Sugita, E T

    Published in Journal of pharmacobio-dynamics (1991)
    “…The sodium salts of the 3,5-dichloro, 3,5-dibromo-, 3,5-diiodo-, and 5-methoxy- analogs of salicylic acid have been evaluated as enhancers of rectal insulin…”
    Get more information
    Journal Article